2016 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.




Enrollment Completed for European PLIANT Registry of Jotec’s E-liac Stent Graft System

June 27, 2016 -- Jotec GmbH announced completion of patient enrollment of the PLIANT postmarket registry. PLIANT is studying patients with iliac aneurysms who are undergo…

FDA Approves Study of New Unitary Manifold Stent Graft System for TAAA

June 21, 2016 -- Sanford Vascular Innovations (SVI), a division of Sanford Health, announced US Food and Drug Administration approval to study a new device to treat complex an…

Endovascular Observational Teamwork Assessment Tool Evaluated

June 22, 2016 -- A multistage, multimethod study that sought to modify, content validate, and evaluate a teamwork assessment tool for use in endovascular surgery was published…

Impact of Chronic Kidney Disease on Femoropopliteal Treatment Outcomes Studied

June 22, 2016 -- Paul P. Heideman, MD, et al conducted a study to evaluate the effect of chronic kidney disease (CKD) on all-cause mortality, major adverse limb event (MALE), …

CE Mark Granted for Lombard Medical’s IntelliFlex LP Delivery System for the Aorfix EVAR Device

June 21, 2016 -- Lombard Medical, Inc. announced that it has received CE Mark approval for its IntelliFlex low-profile (LP) delivery system for the Aorfix stent graft for endo…

Three-Year STRATO Data Support Cardiatis' MFM Device for TAAA Repair

June 20, 2016 -- Three-year outcomes from the STRATO trial were published by Claude D. Vaislic, MD, et al online ahead of print in the Journal of Endovascular Therapy (JEVT). …

ALTITUDE Global Registry Will Evaluate Lombard Medical’s Altura EVAR Device in Real World Patients

June 16, 2016 -- Lombard Medical, Inc. announced plans to conduct a global registry to evaluate its new Altura endograft system for the endovascular aneurysm repair (EVAR) of …

Click here for more News coverage

Current Supplement

Sponsored by Cook Medical

The Next Chapter in TEVAR

Moving Technology Toward Patient Needs

Current European Supplement

Sponsored by Spectranetics

Evidence From the Next-Generation DCB

More With Less

physician counsel

Open Payments Update: Will More Data + More Errors = More Physician Peril?

An early look at samples from the full 2014 Open Payments records suggests that physicians must be ready to review and dispute their records before they go public.

Open Payments Errors Could Put Physicians in a Bad Light

As the Open Payments website becomes more user-friendly, physicians must ensure their disclosures are accurate, or risk misinterpretation.

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center




Vascular Market Price  Change
Abbott Laboratories $36.95  -2.53%
AstraZeneca PLC $27.95  0.32%
Avinger $11.21  -7.81%
Boston Scientific Corporation $21.98  -1.74%
BTG plc $645.00  -0.92%
Cardinal Health $73.69  -2.05%
Cardiovascular Systems Inc. $16.78  -4.69%
CR Bard Inc. $225.03  -0.50%
Edwards Lifesciences Corp. $94.53  -1.57%
Endologix Inc. $11.63  -6.06%
Vascular Market Price  Change
Johnson and Johnson $116.55  0.80%
Lombard Medical, Inc. $1.10  -14.73%
Medtronic, Inc. $82.38  -1.06%
Merit Medical Systems, Inc. $18.44  -1.60%
Penumbra, Inc. $56.68  -2.53%
St. Jude Medical Inc. $76.12  -0.99%
Stryker $114.78  -1.55%
The Medicines Company $33.28  0.06%
The Spectranetics Corporation $16.87  -5.86%
Vascular Solutions Inc. $38.57  1.15%


Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.